title: The phenomenon of spontaneous genetic reversions in the Wiskott-Aldrich syndrome: a report of the workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4-7, 2006.
abstract: The Wiskott-Aldrich syndrome (WAS) is a primary immunodeficiency disease caused by mutations in the Wiskott-Aldrich Protein (WASP) gene, which typically leads to absent WASP protein expression in WAS leukocytes. However, some patients have been found with small populations of WASP-expressing cells caused by reverse or second-site mutations that allow protein expression. An international consortium was established to further investigate these phenomena. This paper summarizes data collected by this consortium that was presented at a workshop held during the XIIth Meeting of the European Society for Immunodeficiencies (ESID), October, 2006. WASP reversions were noted in approximately 11% of 272 patients tested. Many different cell lineages showed reversions. These data form the foundation for further investigation into this phenomenon, which has implications for therapy of this disease.
authors: Immunophysiology Section, Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. dstew@helix.nih.gov
authors: Donn M
authors: DM
authors: Stewart
authors: Fabio
authors: F
authors: Candotti
authors: David L
authors: DL
authors: Nelson
mesh_terms: D000293:Adolescent; D000328:Adult; D019070:Cell Lineage / Q000235:genetics / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D005060:Europe; D006801:Humans; D007223:Infant; D009030:Mosaicism; D009154:Mutation; D012955:Societies, Medical; D014923:Wiskott-Aldrich Syndrome / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D051316:Wiskott-Aldrich Syndrome Protein / Q000096:biosynthesis / Q000172:deficiency / Q000235:genetics / Q000502:physiology
chemical_list: D051316:Wiskott-Aldrich Syndrome Protein
references: J Clin Invest. 1993 Apr;91(4):1816-21
references: 8473520
references: Blood. 1999 Jan 15;93(2):756-7
references: 10215346
references: N Engl J Med. 1996 Nov 21;335(21):1563-7
references: 8900089
references: Hum Mutat. 2006 Apr;27(4):370-5
references: 16511828
references: J Clin Invest. 1994 Oct;94(4):1657-61
references: 7929843
references: Blood. 2004 Jun 15;103(12 ):4565-72
references: 14726382
references: Blood. 2007 Feb 1;109(3):1182-4
references: 17244687
references: Science. 1995 Oct 20;270(5235):475-80
references: 7570001
references: Blood. 2005 Oct 15;106(8):2815-7
references: 15985539
references: Science. 2000 Apr 28;288(5466):669-72
references: 10784449
references: Nat Genet. 1996 Jul;13(3):290-5
references: 8673127
references: Gene Ther. 1999 Jun;6(6):1170-4
references: 10455421
references: J Immunol. 2001 Apr 15;166(8):5245-9
references: 11290809
references: Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8697-702
references: 11447283
references: Blood. 2004 Sep 1;104(5):1270-2
references: 15142877
references: Nat Immunol. 2001 Mar;2(3):223-8
references: 11224521
references: J Clin Invest. 1999 May 15;103(10 ):1371-7
references: 10330419
references: Nat Genet. 1999 Aug;22(4):379-83
references: 10431244
references: J Clin Invest. 2003 May;111(9):1389-97
references: 12727931
references: Eur J Hum Genet. 1997 May-Jun;5(3):137-48
references: 9272737
references: Blood. 2004 Dec 15;104(13):4010-9
references: 15284122
references: Blood. 1995 Nov 15;86(10):3797-804
references: 7579347
references: Cell. 1997 Feb 21;88(4):543-51
references: 9038345